Literature DB >> 19028353

Bone remodelling: its local regulation and the emergence of bone fragility.

T John Martin1, Ego Seeman.   

Abstract

Bone modelling prevents the occurrence of damage by adapting bone structure - and hence bone strength - to its loading circumstances. Bone remodelling removes damage, when it inevitably occurs, in order to maintain bone strength. This cellular machinery is successful during growth, but fails during advancing age because of the development of a negative balance between the volumes of bone resorbed and formed during remodelling by the basic multicellular unit (BMU), high rates of remodelling during midlife in women and late in life in both sexes, and a decline in periosteal bone formation. together resulting in bone loss and structural decay each time a remodelling event occurs. The two steps in remodelling - resorption of a volume of bone by osteoclasts and formation of a comparable volume by osteoblasts - are sequential, but the regulatory events leading to these two fully differentiated functions are not. Reparative remodelling is initiated by damage producing osteocyte apoptosis, which signals the location of damage via the osteocyte canalicular system to endosteal lining cells which forms the canopy of a bone-remodelling compartment (BRC). Within the BRC, local recruitment of osteoblast precursors from the lining cells, the marrow and circulation, direct contact with osteoclast precursors, osteoclastogenesis and molecular cross-talk between precursors, mature cells, cells of the immune system, and products of the resorbed matrix, titrate the birth, work and lifespan of the cells of this multicellular remodelling machinery to either remove or form a net volume of bone appropriate to the mechanical requirements.

Entities:  

Mesh:

Year:  2008        PMID: 19028353     DOI: 10.1016/j.beem.2008.07.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  35 in total

1.  Effect of stress on mRNA expression of H+-ATPase in osteoclasts.

Authors:  Zhang Qing Hong; Liu Meng Tao; Liu Li
Journal:  Mol Cell Biochem       Date:  2010-06-12       Impact factor: 3.396

2.  NOX4 Deletion in Male Mice Exacerbates the Effect of Ethanol on Trabecular Bone and Osteoblastogenesis.

Authors:  James Watt; Alexander W Alund; Casey F Pulliam; Kelly E Mercer; Larry J Suva; Jin-Ran Chen; Martin J J Ronis
Journal:  J Pharmacol Exp Ther       Date:  2018-04-13       Impact factor: 4.030

Review 3.  Biglycan in the Skeleton.

Authors:  Vardit Kram; Reut Shainer; Priyam Jani; Josephina A N Meester; Bart Loeys; Marian F Young
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

4.  Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors.

Authors:  T Y Zhu; J F Griffith; L Qin; V W Y Hung; T-N Fong; S-K Au; A W Kwok; P-C Leung; E K Li; L-S Tam
Journal:  Osteoporos Int       Date:  2014-08-27       Impact factor: 4.507

Review 5.  The calcium-sensing receptor in bone metabolism: from bench to bedside and back.

Authors:  L Cianferotti; A R Gomes; S Fabbri; A Tanini; M L Brandi
Journal:  Osteoporos Int       Date:  2015-06-23       Impact factor: 4.507

6.  Adenosine A(2A) receptor ligation inhibits osteoclast formation.

Authors:  Aránzazu Mediero; Firas M Kara; Tuere Wilder; Bruce N Cronstein
Journal:  Am J Pathol       Date:  2011-11-30       Impact factor: 4.307

7.  Registration-Based Morphometry for Shape Analysis of the Bones of the Human Wrist.

Authors:  Anand A Joshi; Richard M Leahy; Ramsey D Badawi; Abhijit J Chaudhari
Journal:  IEEE Trans Med Imaging       Date:  2016-02       Impact factor: 10.048

8.  The effects of Exendin-4 on bone marrow-derived mesenchymal cells.

Authors:  Paola Luciani; Benedetta Fibbi; Benedetta Mazzanti; Cristiana Deledda; Lara Ballerini; Alessandra Aldinucci; Susanna Benvenuti; Riccardo Saccardi; Alessandro Peri
Journal:  Endocrine       Date:  2017-11-01       Impact factor: 3.633

Review 9.  Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene.

Authors:  Luigi Gennari; Daniela Merlotti; Ranuccio Nuti
Journal:  Clin Interv Aging       Date:  2010-02-02       Impact factor: 4.458

10.  Skeletal growth and the changing genetic landscape during childhood and adulthood.

Authors:  Dana L Duren; Maja Seselj; Andrew W Froehle; Ramzi W Nahhas; Richard J Sherwood
Journal:  Am J Phys Anthropol       Date:  2013-01       Impact factor: 2.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.